By Puyaan Singh Jan 12 (Reuters) - Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO Daniel O'Day said at a major industry ...

Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...

The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that causes AIDS. The injectable drug lenacapavir was approved in June and is ...

A controversial advertisement in DC about an HIV prevention pill has some people calling the commercial effective, but others said the city is taking things too far. Ten years ago, nearly four people ...

A handout photo made available on September 19, 2025 by Unitaid/Gilead Sciences, Inc shows the generic version of the new HIV prevention tool, injectable Lenacapavir. [AFP] The United States said ...

(The Root) — On Monday the U.S. Food and Drug Administration approved the first pill to prevent HIV infection in adults who do not have the virus — but are at risk of becoming infected. Studies have ...

South Africa, Eswatini and Zambia were to begin on Monday administering a groundbreaking new HIV-prevention injection in the drug's first public rollouts in Africa, which has the world's highest HIV ...

Jan 12 (Reuters) - Gilead Sciences' (GILD.O), opens new tab new HIV prevention drug has been added to CVS Health's (CVS.N), opens new tab commercial insurance plans, the drugmaker's CEO Daniel O'Day ...